UCLA and Cedars-Sinai build a glioblastoma mouse model that resists immunotherapy like patients
anne_churchland · x · 2026-11-07
UCLA and Cedars-Sinai researchers built a new glioblastoma mouse model that better mirrors human disease, capturing the tumor's immune-suppressive environment and showing checkpoint-blockade resistance like patient tumors — a better testbed for studying why therapies fail.
More from Research
- Regularization amplifies subliminal learning instead of blocking hidden biases, thread finds — AdtRaghunathan · 2026-11-07
- Your LLM Is Secretly a Reward Model: Revisiting Stanford's DPO Paper — dotey · 2026-11-07
- RareDiseaseBench debuts: 35 reconstructed rare disease cases test AI diagnostic agents — kenbwork · 2026-11-07
- With ETH Refuted, GNN Chains Tackle the Still-Hard Graph Alignment Problem — marc_lelarge · 2026-11-07
- CMU L3 Lab CUA Week: GPT-6 Astra Passes Only 9% of Real-Time Minigames — dan_fried · 2026-11-07
- NYU's Witnesses lets researchers prove what data their AI training used, no rerun needed — pratyusha_PS · 2026-11-07